Fig. 3From: Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC RegistryAnnual progression rate of disability scale scores from enrollment to the last follow-up visit in patients continuously treated with miglustat. CI, confidence intervalBack to article page